Investment Summary

EQT Life Sciences Invests In Aelin Therapeutics

On December 11, 2017, growth capital firm EQT Life Sciences invested in life science company Aelin Therapeutics

Investment Highlights
  • This is EQT Life Sciences’ 9th transaction in the Life Science sector.
  • This is EQT Life Sciences’ 2nd transaction in Belgium.

Investment Summary

Date 2017-12-11
Target Aelin Therapeutics
Sector Life Science
Investor(s) EQT Life Sciences
Deal Type Venture

Target

Aelin Therapeutics

Leuven, Belgium
Aelin Therapeutics is pioneering a novel modality in drug development in order to create a completely new class of antibiotics and first-in-class therapeutics against high-value undruggable human targets. The technology, branded Pept-ins™ harnesses the power of protein aggregation to specifically induce functional knockdown of a target protein. Aelin Therapeutics is based in Leuven, Belgium.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

EQT Life Sciences


Category Growth Capital Firm
Founded 1987
PE ASSETS 3.5B EUR
Size Large
Type Sector Focused
DESCRIPTION

EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.


DEAL STATS #
Overall 17 of 47
Sector: Life Science M&A 9 of 30
Type: Venture M&A Deals 14 of 39
Country: Belgium M&A 2 of 5
Year: 2017 M&A 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-19 Simplify

Sunnyvale, California, United States

Simplify is a medical device company focused on cervical spinal disc arthroplasty, using innovative, MRI-compatible materials designed to optimize diagnostic imaging and decrease the need for ionizing radiation. Simplify was founded in 2013 and is based in Sunnyvale, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-10 Artios

Cambridge, United Kingdom

Artios is committed to discovering and developing groundbreaking DDR therapeutics to help patients suffering from a broad range of devastating and difficult-to-treat cancers. Artios was founded in 2015 and is based in Cambridge, United Kingdom.

Buy -